Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-113-5 | CAS number: 7440-03-1
Endpoint summary
Administrative data
Description of key information
Niobium was negative in the murine LLNA.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2009-08-31 to 2009-10-23
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann, Borchen, Germany
- Age at study initiation: 8-9 weeks
- Weight at study initiation: 15-22 g
- Housing: in groups of 5 in IVC cages, type II L, polysulphone cages on Altromin saw fibre bedding
- Diet (ad libitum): ad libitum
- Water (ad libitum): ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+-3
- Humidity (%): 55+-10
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light):12/12
IN-LIFE DATES: From: 2009-09-11 To: 2009-10-01 - Vehicle:
- other: acetone / oilive oil 3:1 (v/v)
- Concentration:
- 25%, 50%, 100% (based on the results of the preliminary test)
- No. of animals per dose:
- 5
- Details on study design:
- Preliminary test to test the highest tolerable and non-irritant dose (two animals used).
Two animals were treated by topical application of the test substance onto the entire dorsal surface of each ear for 3 consecutive days with 100% test item diluted in vehicle. An additional animal were treated with 100% vehicle and served as negative control. From day 1 to day 4 the ear thickness of each animal was measured.
MAIN STUDY
Each mouse was treated by topical application of 25 µL of the respective test substance solution or negative (vehicle) control onto the entire dorsal surface of the ear.
Topical applications were perforemed once daily for three consecutive days.
5 days after the first topical application all miced received 20 µCi 3H-methyl thymidine by intravenous injection.
5 hours later all mice were sacrificed. The draining auricular lymph nodes were excised, individually pooled for each animal and collected in PBS.
A single cell suspension of pooled lymphe node cells were prepared, washed and prepared for scintillation counting.
Incorporated 3H-methyl thymidine was measured by scintillatzion counting, and stimulation indices were determined.
OTHER:
Reliability checks with a positive control substance was performed periodically in the performing laboratory. - Positive control substance(s):
- other: P-Phenylenediamine (CAS 106-50-3)
- Positive control results:
- Reliability checks with a positive control substance was performed periodically in the performing laboratory. The mean SI-value of the latest reliability check was 13.8.
- Parameter:
- SI
- Value:
- 1.2
- Test group / Remarks:
- 25%
- Parameter:
- SI
- Value:
- 1.1
- Test group / Remarks:
- 50%
- Parameter:
- SI
- Value:
- 2.1
- Test group / Remarks:
- 100%
- Cellular proliferation data / Observations:
- DPM (mean values):
DPM for negative control: 1251.5 DPM at an extract concentration of 25%: 1507.3 DPM at an extract concentration of 50%: 1428.4 DPM at an extract concentration of 100%: 2618.6 - Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification according to Regulation (EC) No 1272/2008
- Conclusions:
- According to OECD guideline 429 and EU criteria the test substance should not be classified for dermal sensitization.
CLP: not classified
Reference
All animals survived throughout the test period without showing any clinical signs. All animals gained weight as expected.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Niobium did not stimulate lymphocyte proliferation. In a murine LLNA a maximum SI of 2.1 was observed.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
No classification as skin sensitizer is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
